What is he best known for?
The fields of study he is best known for:
- Cancer
- Internal medicine
- Gene
His primary areas of study are Colorectal cancer, Internal medicine, KRAS, Microsatellite instability and Cancer.
His Colorectal cancer study combines topics from a wide range of disciplines, such as Cancer research, Molecular pathological epidemiology, Prospective cohort study, Pathology and Hazard ratio.
His Internal medicine research includes themes of Immunology, Gastroenterology and Oncology.
His research investigates the link between KRAS and topics such as Carcinoma that cross with problems in Epidemiology of cancer, Mucinous carcinoma, Signet ring cell and Signet ring cell carcinoma.
Shuji Ogino focuses mostly in the field of Microsatellite instability, narrowing it down to topics relating to CpG Island Methylator Phenotype and, in certain cases, MLH1 and CpG site.
As a part of the same scientific study, Shuji Ogino usually deals with the Cancer, concentrating on Proportional hazards model and frequently concerns with Survival analysis.
His most cited work include:
- Tumour micro-environment elicits innate resistance to RAF inhibitors through HGF secretion (1266 citations)
- Genomic analysis identifies association of Fusobacterium with colorectal carcinoma (1060 citations)
- Long-Term Colorectal-Cancer Incidence and Mortality after Lower Endoscopy (847 citations)
What are the main themes of his work throughout his whole career to date?
His scientific interests lie mostly in Colorectal cancer, Internal medicine, Oncology, Cancer and Cancer research.
Shuji Ogino studies KRAS which is a part of Colorectal cancer.
His Internal medicine study frequently links to related topics such as Gastroenterology.
Shuji Ogino interconnects Endocrinology, Epidemiology, PTPRC, Immunology and Survival analysis in the investigation of issues within Oncology.
His Cancer research research focuses on DNA methylation and how it connects with Methylation, Molecular biology and Epigenetics.
His Microsatellite instability course of study focuses on MLH1 and CDKN2A.
He most often published in these fields:
- Colorectal cancer (91.63%)
- Internal medicine (83.65%)
- Oncology (50.32%)
What were the highlights of his more recent work (between 2019-2021)?
- Internal medicine (83.65%)
- Colorectal cancer (91.63%)
- Oncology (50.32%)
In recent papers he was focusing on the following fields of study:
Shuji Ogino mostly deals with Internal medicine, Colorectal cancer, Oncology, Cancer and Odds ratio.
His study looks at the relationship between Internal medicine and fields such as Gastroenterology, as well as how they intersect with chemical problems.
The study incorporates disciplines such as Incidence, Cohort study, Lower risk, Microsatellite instability and Proportional hazards model in addition to Colorectal cancer.
In his study, which falls under the umbrella issue of Microsatellite instability, Tumor microenvironment and CD8 is strongly linked to Cancer research.
His Oncology research includes elements of Genome-wide association study, Single-nucleotide polymorphism, KRAS, Survival analysis and Risk factor.
His study in Cancer is interdisciplinary in nature, drawing from both Meta-analysis and Immune system.
Between 2019 and 2021, his most popular works were:
- The urgent need for integrated science to fight COVID-19 pandemic and beyond. (66 citations)
- Long-term Risk of Colorectal Cancer After Removal of Conventional Adenomas and Serrated Polyps (42 citations)
- Circulating Levels of Insulin-like Growth Factor 1 and Insulin-like Growth Factor Binding Protein 3 Associate With Risk of Colorectal Cancer Based on Serologic and Mendelian Randomization Analyses. (20 citations)
In his most recent research, the most cited papers focused on:
- Cancer
- Internal medicine
- Gene
His primary scientific interests are in Colorectal cancer, Internal medicine, Oncology, Odds ratio and Prospective cohort study.
His Colorectal cancer research is multidisciplinary, incorporating elements of Gastroenterology, Cancer research, Proportional hazards model and Microsatellite instability.
His Cancer research research is multidisciplinary, relying on both Tumor microenvironment, CD8, Medical genetics, MAP2K4 and Adenocarcinoma.
His research investigates the connection with Microsatellite instability and areas like Molecular pathological epidemiology which intersect with concerns in BECN1, Real-time polymerase chain reaction and Metagenomics.
Shuji Ogino has included themes like Genome-wide association study, Single-nucleotide polymorphism, Cohort study and Hazard ratio, Confidence interval in his Oncology study.
In his work, Meta-analysis is strongly intertwined with Risk factor, which is a subfield of Prospective cohort study.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
